Remove Pricing Remove Screening Remove Study Remove Technical Review
article thumbnail

Why Entrepreneurs Hate (Most) MBAs

InfoChachkie

Tech entrepreneurs' consternation with MBAs does not rise to the level of loathing. Rather, entrepreneurs' frustrations are often due to an incongruence between an MBA's expectations versus the value they can deliver to a startup. As I stated in my Quora answer, "hate" is the wrong word. Look For MBA Outliers.

article thumbnail

Bio Roundup: Cancer Wishes and Shopping Lists, Allergan Pricing & More

Xconomy

The agency advised women and their doctors not to use screening tests that claim to detect ovarian cancer. —One cancer screening test got positive news from a federal agency. —Bay Area regulatory blues: Biomarin Pharmaceutical (NASDAQ: BMRN ) of San Rafael, CA, had its FDA review of cerliponase alfa (Brineura) delayed.

Pricing 40
article thumbnail

US Economic Risks (Sept 2010): Impact on Investors & Entrepreneurs

Both Sides of the Table

The prices of angel deals have recently crept up, VCs have also gotten their checkbooks out again, frothy deals are happening and people are feeling bullish. Here talking about lithium-ion batteries and the early lead we’ve squandered in that market: “ With some technologies, both scaling and innovation take place overseas.